(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APGALLA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

APGALLA

ST13

US500000079332041

Class

5

Filing

79332041

Registration

6784274

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

08/12/2025

Trademark type

Word

Nice classes

5

Filing date

12/17/2021

Registration date

07/12/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/12/2022

Last transaction

08/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

JAGDEO, KARA

Law office

T30

Current location

PETITIONS OFFICE

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

25 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/11/2025

GPNX

NOTIFICATION PROCESSED BY IB

09/25/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/06/2022

FIMP

FINAL DISPOSITION PROCESSED

09/06/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/11/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/12/2022

CHPB

POST PUBLICATION AMENDMENT - ENTERED

06/09/2022

APET

ASSIGNED TO PETITION STAFF

06/06/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

05/17/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/26/2022

PUBO

PUBLISHED FOR OPPOSITION

04/26/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/17/2022

DOCK

ASSIGNED TO EXAMINER

03/17/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/07/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/07/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/07/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/07/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/07/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/07/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/09/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/02/2022

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

01/27/2022

Continuous trademark protection

Get notified about every new filing that threatens APGALLA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.